Skip to main content
. 2021 Aug 31;13(9):1740. doi: 10.3390/v13091740

Figure 1.

Figure 1

Development of oHSV: from discovery to clinical trial (CT) and approval as oncolytic agent. The center of the text corresponds to the year.